Skip to content

Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract

Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract: Benefit of Use of the Enhance Retina Visualization Mode

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05239715
Acronym
BIO-CAT-DENSA
Enrollment
51
Registered
2022-02-15
Start date
2022-02-10
Completion date
2022-10-31
Last updated
2023-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optical Biometer, Cataracts

Keywords

optical biometer, cataracts

Brief summary

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Detailed description

To describe and compare the acquisition rate between different biometers in eyes with advanced cataracts

Interventions

DIAGNOSTIC_TESTOcular biometry

Biometry using swept-source OCT Argos, swept-source OCT IOLMaster 700, swept-source OCT Anterion, PCI Pentacam AXL, OcuScan RxP and Itrace measurement

Sponsors

Alcon Research
CollaboratorINDUSTRY
OFTALVIST (Oftalmología Vistahermosa S.L)
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* LOCS III cataract classification with a grade of ≥3 for nuclear, cortical or posterior subcapsular. * DLI index, from the ITrace device, should be ≤ 5.

Exclusion criteria

* Previous continuous contact lens wear * Ocular trauma * Intraocular lens surgery * Poor fixation * Corneal disease (i.e. keratoconus)

Design outcomes

Primary

MeasureTime frameDescription
To describe and compare the acquisition rate between different biometers in eyes To describe and compare the acquisition success rate between different biometers in eyes with advanced cataracts6 monthsAcquision succes rate is indicated by a percentage, from 0% to 100%. The biometer can obtain (success) or not (failure) the measurement. This value will be indicated for each biometer.

Secondary

MeasureTime frame
To describe the correlation of success rate and Dysfunctional Lens Index (DLI, iTrace)6 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026